← Eichor
Condition: Renal Cyst Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Renal Cyst

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to See if Tolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old With
Phase 3 · 23 location(s) · Otsuka Pharmaceutical Development & Commercialization, Inc. · NCT04782258Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT00033137ARPKD Database Study
Phase N/A · 6 location(s) · Children's Hospital of Philadelphia · NCT01401998Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT0179316868Ga-NYM096 PET/ CT for the Detection of ccRCC in Presurgical Patients With Complex Cystic Renal Leision
Phase 2 · 1 location(s) · Peking Union Medical College Hospital · NCT06949215The Myelin Disorders Biorepository Project
Phase N/A · 23 location(s) · Children's Hospital of Philadelphia · NCT03047369National Registry of Rare Kidney Diseases
Phase N/A · 1 location(s) · UK Kidney Association · NCT06065852A Prospective Observational Study of Foam Sclerotherapy .
Phase N/A · 1 location(s) · Mayo Clinic · NCT04111692Surveillance of Complex Renal Cysts - The SOCRATIC Study
Phase N/A · 18 location(s) · Université de Sherbrooke · NCT04558593
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.